Paratek Pharmaceuticals (PRTK) Competitor Comparison
We are evaluating the key criteria listed to compare Paratek Pharmaceuticals (PRTK) against its competitors in the Biotechnology industry.
Market Capitalization
250 / 368Gross Profits
45 / 278Total Revenue
64 / 300EBITDA
132 / 337Free Cashflow
149 / 352Quick Ratio
346 / 357Earnings per Share
140 / 359Dividend yield
0 / 6Total Cash
268 / 358Performance 3 years
183 / 368Performance 5 years
224 / 368Performance 10 years
275 / 368Linearity 3 years
93 / 368Linearity 5 years
225 / 368Linearity 10 years
237 / 368Total Rank
223 / 368Dividend Rank
233 / 368Valuation Rank
113 / 368Piotroski Rank
302 / 368Muliplier Rank
71 / 368Earnings per Share - PRTK ranking 140 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.